Literature DB >> 21508379

Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma.

Daisuke Uejima1, Koichi Nishijo, Yoichiro Kajita, Tatsuya Ishibe, Tomoki Aoyama, Susumu Kageyama, Hideaki Iwaki, Takashi Nakamura, Hirokazu Iida, Tatsuhiro Yoshiki, Junya Toguchida.   

Abstract

BACKGROUND: Up-regulation of the expression of the gene C7orf24, encoding γ-glutamyl cyclotransferase, is a common event in cancers derived from various tissues, but its involvement in osteosarcomas (OS) has not yet been demonstrated.
MATERIALS AND METHODS: The expression of C7orf24 was analyzed in human OS cell lines and primary tumor samples. The biological effects of C7orf24 on growth, motility, and invasion in the OS cell lines were investigated using siRNA for C7orf24. Genes related to the function of C7orf24 were sought by genome-wide gene expression profiling.
RESULTS: The level of C7orf24 expression was much higher in the OS cell lines and OS primary tumors than in normal osteoblasts. Down-regulation of C7orf24 expression inhibited the growth of the cell lines in association with enhancement of cell-clustering. Treatment with C7orf24-siRNA inhibited cell motility and invasion. Gene ontology suggested the function of C7orf24 to be related to cell adhesion and protein transport.
CONCLUSION: C7orf24 is also involved in the growth of OS, and is a potential biomarker for this type of tumor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508379

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Widespread expression of γ-glutamyl cyclotransferase suggests it is not a general tumor marker.

Authors:  Tomonari Amano; Yoshinobu Eishi; Tetsuo Yamada; Keisuke Uchida; Kana Minegishi; Tomoki Tamura; Daisuke Kobayashi; Kawachi Hiroshi; Takashige Suzuki; Philip G Board
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

Review 2.  Emerging regulatory paradigms in glutathione metabolism.

Authors:  Yilin Liu; Annastasia S Hyde; Melanie A Simpson; Joseph J Barycki
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

3.  Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.

Authors:  Wan I Wan-Ibrahim; Vivek A Singh; Onn H Hashim; Puteri S Abdul-Rahman
Journal:  Mol Med       Date:  2015-11-13       Impact factor: 6.354

4.  γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis.

Authors:  Keiko Taniguchi; Susumu Kageyama; Chiami Moyama; Shota Ando; Hiromi Ii; Eishi Ashihara; Mano Horinaka; Toshiyuki Sakai; Shigehisa Kubota; Akihiro Kawauchi; Susumu Nakata
Journal:  Cancer Gene Ther       Date:  2021-01-05       Impact factor: 5.987

5.  GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition.

Authors:  Qi Huang; Yuanhang Zhou; Yue Li; Zhiwei Liao
Journal:  Oncol Lett       Date:  2020-05-30       Impact factor: 2.967

6.  Ras Downstream Effector GGCT Alleviates Oncogenic Stress.

Authors:  Zaoke He; Shixiang Wang; Yuanyuan Shao; Jing Zhang; Xiaolin Wu; Yuxing Chen; Junhao Hu; Feng Zhang; Xue-Song Liu
Journal:  iScience       Date:  2019-07-26

7.  Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.

Authors:  Zhipeng Wang; Shuang Liang; Xin Lian; Lei Liu; Shu Zhao; Qijia Xuan; Li Guo; Hang Liu; Yuguang Yang; Tieying Dong; Yanchen Liu; Zhaoliang Liu; Qingyuan Zhang
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.996

Review 8.  Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.

Authors:  Susumu Kageyama; Eiki Hanada; Hiromi Ii; Keiji Tomita; Tatsuhiro Yoshiki; Akihiro Kawauchi
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 9.  Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy.

Authors:  Susumu Kageyama; Hiromi Ii; Keiko Taniguchi; Shigehisa Kubota; Tetsuya Yoshida; Takahiro Isono; Tokuhiro Chano; Taku Yoshiya; Kosei Ito; Tatsuhiro Yoshiki; Akihiro Kawauchi; Susumu Nakata
Journal:  Int J Mol Sci       Date:  2018-07-14       Impact factor: 5.923

10.  Oxidative and Antioxidative Status Expressed as OSI Index and GSH/GSSG Ratio in Children with Bone Tumors after Anticancer Therapy Completion.

Authors:  Joanna Gajewska; Magdalena Chełchowska; Magdalena Rychłowska-Pruszyńska; Teresa Klepacka; Jadwiga Ambroszkiewicz
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.